| 0.9 |
10.1 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.6 |
3.1 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.5 |
1.6 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.5 |
1.5 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.3 |
1.3 |
GO:0055099 |
regulation of Cdc42 protein signal transduction(GO:0032489) response to high density lipoprotein particle(GO:0055099) platelet dense granule organization(GO:0060155) |
| 0.3 |
1.2 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.3 |
0.9 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
2.1 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 |
2.6 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.3 |
0.9 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) |
| 0.3 |
0.9 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 |
0.8 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.3 |
1.0 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
2.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 |
2.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.2 |
1.1 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.2 |
2.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.2 |
0.7 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.2 |
2.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
1.4 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.2 |
0.8 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 |
1.0 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.2 |
2.2 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
0.6 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.2 |
0.7 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
0.9 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.2 |
0.7 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
| 0.2 |
1.2 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.2 |
0.5 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.1 |
0.6 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.7 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.1 |
0.7 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.1 |
2.6 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 |
0.4 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.4 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.6 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.4 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 |
0.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
1.0 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
0.6 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 |
0.4 |
GO:0050929 |
corticospinal neuron axon guidance(GO:0021966) corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.1 |
0.9 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.1 |
0.6 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
1.7 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 |
0.6 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
1.3 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.4 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.1 |
0.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.3 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 |
0.7 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
0.4 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.1 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.7 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.4 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.1 |
1.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
1.0 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
0.2 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.2 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.1 |
0.4 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.6 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
2.7 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.9 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
0.4 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 |
0.2 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.1 |
1.4 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 |
0.3 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
0.1 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.1 |
0.3 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.5 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.2 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.3 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
1.1 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
0.5 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.1 |
0.3 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
0.3 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.3 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.2 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 |
0.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.8 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.0 |
0.5 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.0 |
0.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.0 |
0.4 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.2 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.0 |
0.4 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
1.1 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 |
0.2 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.0 |
0.2 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.1 |
GO:0086069 |
desmosome assembly(GO:0002159) bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.0 |
0.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.0 |
0.2 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.0 |
0.1 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.0 |
0.2 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.5 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.2 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.0 |
0.1 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.0 |
0.1 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.0 |
1.1 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.1 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.0 |
0.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.1 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.0 |
0.3 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.0 |
0.1 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.0 |
0.4 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.0 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 |
0.1 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.0 |
0.2 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.0 |
0.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.2 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.2 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.8 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.1 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.0 |
1.4 |
GO:0010828 |
positive regulation of glucose transport(GO:0010828) |
| 0.0 |
0.1 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 |
0.6 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.1 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 |
0.4 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.0 |
GO:0034239 |
regulation of macrophage fusion(GO:0034239) |
| 0.0 |
0.1 |
GO:0090194 |
hyaluranon cable assembly(GO:0036118) negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) negative regulation of cell proliferation involved in kidney development(GO:1901723) |
| 0.0 |
0.1 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
1.2 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.1 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.0 |
0.3 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
1.0 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.2 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.8 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.2 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.2 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.0 |
0.7 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.5 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.0 |
0.2 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 |
0.6 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.0 |
0.0 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.0 |
0.1 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.1 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
0.1 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.3 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.4 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.2 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 |
0.0 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.6 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.0 |
0.2 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
1.1 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.2 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.1 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.1 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.0 |
0.3 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.3 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.2 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.2 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.1 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.1 |
GO:0071578 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.3 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.2 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
